Elevated protease HtrA4 in the maternal circulation of preeclampsia may contribute to endothelial barrier disruption by cleaving key junctional protein VE-cadherin
Authors:
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council of Australia (#1041835, #1108365)
- Victorian State Government Operational Infrastructure Scheme
This publication has 10 references indexed in Scilit:
- Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsiaJournal of Endocrinology, 2017
- Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic womenAmerican Journal of Obstetrics and Gynecology, 2015
- Human HtrA4 Expression Is Restricted to the Placenta, Is Significantly Up-Regulated in Early-Onset Preeclampsia, and High Levels of HtrA4 Cause Endothelial DysfunctionThe Journal of Clinical Endocrinology & Metabolism, 2015
- Difference of endothelial function during pregnancies as a method to predict preeclampsiaArchives of Gynecology and Obstetrics, 2014
- The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHPPregnancy Hypertension, 2014
- PAR-2 triggers placenta-derived protease-induced altered VE-cadherin reorganization at endothelial junctions in preeclampsiaPlacenta, 2012
- VE-CadherinArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Soluble endoglin contributes to the pathogenesis of preeclampsiaNature Medicine, 2006
- Placental Trophoblast-Derived Factors Diminish Endothelial Barrier FunctionThe Journal of Clinical Endocrinology & Metabolism, 2004
- Endothelial junctional protein redistribution and increased monolayer permeability in human umbilical vein endothelial cells isolated during preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2002